Analysis of bone microstructure using second-generation high-resolution peripheral quantitative computed tomography (HR-pQCT) in patients with Cushing syndrome

Analysis of bone microstructure using second-generation high-resolution peripheral quantitative computed tomography (HR-pQCT) in patients with Cushing syndrome - Analysis of bone microstrucure using HR-pQCT in Cushing syndrome

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038532

Enrollment

Registered

2019-11-10

Start date

2020-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cushing syndrome

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with Cushing syndrome based on the criteria of Japan Endocrine socitety

Exclusion criteria

Exclusion criteria: 1. Patients who was administered within 3 months with teriparatide, denosumab and romosozumab. 2. Patinets administered with steroids. 3. Patients compricated with malignancy. 4. Pregnant or brest feeding.

Design outcomes

Primary

Measure	Time frame
Bone microstructure compared to those of healthy control.	—

Secondary

Measure	Time frame
Changes in bone microstructure in patients with Cushing syndrome from baseline to 1 or 2 years after adrenalectomy.	—

Countries

Japan

Contacts

Public ContactHorie Ichiro

Nagasaki University Hospital Department of Endocrinology and Metabolism

horie@nagasaki-u.ac.jp0958197200

Outcome results